Literature DB >> 16919055

Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients.

E Quintela1, J Castillo, P Muñoz, J Pascual.   

Abstract

The nosology of migraine premonitory (PS) and resolution (RS) symptoms was studied in 100 migraineurs consulting their general physician. They were asked to fill in, for three attacks, a PS and RS questionnaire. 'True' PS/RS were those experienced the day before (or the day after) the headache had started only if they were not present in a questionnaire completed in a pain-free period. True PS and RS were experienced by 84% and 80%, respectively, of subjects for the first attack. The mean and range (per patient) of PS were 6.8 and 0-21 and of RS 4.7 and 0-15. Anxiety, phonophobia, irritability, unhappiness and yawning were the commonest PS, whereas asthenia, tiredness, somnolence and concentration difficulties were the most common RS. Gender, age and Migraine Disability Assessment scores did not influence PS and RS. Both PS and RS were more frequent in migraine with aura subjects. Patients on preventatives showed a decreased frequency of PS and, to a lesser degree, of RS. Severity of headache was associated with a higher frequency of RS. Individual RS and especially PS were quite consistent after three attacks. Almost two-thirds of the symptoms were noticed in at least two out of three attacks, while more than a half of PS and more than a quarter of RS repeated in three out of three attacks. In conclusion, around 80% of unselected migraineurs experience RS and PS. Migraine with aura and severe pain are risk factors for experiencing PS and RS, while preventatives were protective, especially for PS.

Entities:  

Mesh:

Year:  2006        PMID: 16919055     DOI: 10.1111/j.1468-2982.2006.01157.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  36 in total

Review 1.  Migraine and trigeminal system-I can feel it coming….

Authors:  Antonio Russo; Alessandro Tessitore; Gioacchino Tedeschi
Journal:  Curr Pain Headache Rep       Date:  2013-10

Review 2.  Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism.

Authors:  G D'Andrea; S Cevoli; D Colavito; A Leon
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

Review 3.  Neuropsychiatric Disorders as Erratic Attention Regulation - Lessons from Electrophysiology.

Authors:  Goded Shahaf
Journal:  Psychiatr Q       Date:  2019-12

4.  Hypothalamic regulation of headache and migraine.

Authors:  Arne May; Rami Burstein
Journal:  Cephalalgia       Date:  2019-08-29       Impact factor: 6.292

5.  Altered speech with migraine attacks: A prospective, longitudinal study of episodic migraine without aura.

Authors:  Todd J Schwedt; Jacob Peplinski; Pamela Garcia-Filion; Visar Berisha
Journal:  Cephalalgia       Date:  2018-11-17       Impact factor: 6.292

Review 6.  Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging.

Authors:  Arne May
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

7.  Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.

Authors:  Vincent T Martin; Jeanne Ballard; Michael P Diamond; Lisa K Mannix; Frederick J Derosier; Shelly E Lener; Alok Krishen; Susan A McDonald
Journal:  J Womens Health (Larchmt)       Date:  2014-02-28       Impact factor: 2.681

Review 8.  Cerebral hemodynamics in the different phases of migraine and cluster headache.

Authors:  Jakob M Hansen; Christoph J Schankin
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-31       Impact factor: 6.200

9.  Survey of migraine sufferers with dogs to evaluate for canine migraine-alerting behaviors.

Authors:  Dawn A Marcus; Amrita Bhowmick
Journal:  J Altern Complement Med       Date:  2012-12-04       Impact factor: 2.579

10.  High prevalence of Dopaminergic Premonitory Symptoms in migraine patients with Restless Legs Syndrome: a pathogenetic link?

Authors:  Daniela Cologno; Giulio Cicarelli; Vittorio Petretta; Florindo d'Onofrio; Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.